Jack Kaye

Director

Jack Kaye (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in uniQure N.V. (QURE). The largest single filing was $1.2M of QURE (38,810 sh across 3 lots, as filed), executed Nov 4 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Jun 30

Filed Jul 2

Median ADV $90.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

QURE

uniQure N.V. QURE · 0 buys · 4 sells 4 filings

Recent filings

QURESALE uniQure N.V. View filing → $983K
21,167 sh across 2 lots
Exec Jun 30
Filed Jul 2 · 4:54 PM ET QURESALE uniQure N.V. View filing → $225K
5,295 sh × $42.57
Exec Jun 17
Filed Jun 22 · 5:30 PM ET QURESALE uniQure N.V. View filing → $174K
6,390 sh × $27.28
Exec Jan 9
Filed Jan 12 · 5:30 PM ET QURESALE uniQure N.V. View filing → $1.2M
38,810 sh across 3 lots
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET